Bryn Mawr Trust Advisors LLC Makes New $756,000 Investment in HCA Healthcare, Inc. $HCA

Bryn Mawr Trust Advisors LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 1,598 shares of the company’s stock, valued at approximately $756,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Palisade Asset Management LLC bought a new position in HCA Healthcare during the third quarter worth $26,000. Holos Integrated Wealth LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at about $29,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at about $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $33,000. Finally, Cedar Mountain Advisors LLC acquired a new stake in HCA Healthcare in the first quarter valued at approximately $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the topic of a number of recent research reports. Wells Fargo & Company reduced their price target on shares of HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating for the company in a research report on Monday. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 7th. Oppenheimer dropped their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Leerink Partners dropped their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Royal Bank Of Canada decreased their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $491.77.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA said preliminary second-quarter revenue came in above Wall Street expectations, suggesting demand and patient volumes remained solid enough to support top-line growth. Reuters: HCA reports preliminary quarterly revenue above expectations
• Neutral Sentiment: KeyCorp lowered its price target to $475 from $510 but kept an overweight rating, while Wells Fargo trimmed its target to $428 and maintained an equal weight rating, signaling some caution but not a full bearish call. Benzinga: Analyst updates on HCA Healthcare
• Negative Sentiment: HCA reduced its full-year EPS guidance to 28.7 to 30.5, below consensus, indicating margin pressure and a softer profit outlook for the rest of the year.
• Negative Sentiment: Management cited payer mix shifts tied to health insurance exchanges, along with rising uninsured patients and declining surgeries, as factors squeezing quarterly earnings and hurting expectations. WSJ: HCA Healthcare shares drop after quarterly earnings squeezed by payer mix shifts
• Negative Sentiment: Barron’s reported that the stock fell after the company lowered its outlook, reinforcing investor concern that the strong revenue trend may not translate into comparable profit growth. Barrons: HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook

HCA Healthcare Trading Down 6.7%

HCA Healthcare stock opened at $364.46 on Wednesday. The business’s 50 day simple moving average is $395.39 and its 200 day simple moving average is $458.95. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market cap of $80.85 billion, a price-to-earnings ratio of 12.53, a PEG ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.